Clinical Trials on Stage IB Breast Cancer in Portugal
Total 136 results
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
Grupo LusófonaFundação para a Ciência e a Tecnologia; Faculdade de Motricidade HumanaRecruitingBreast Cancer Female | Hormone-receptor-positive Breast CancerPortugal
-
University of CoimbraIPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade...Recruiting
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
Puma Biotechnology, Inc.CompletedHER2 Amplified Breast CancerPortugal
-
Centro Hospitalar Lisboa OcidentalUnknownBreast Cancer Female | Hormone Dependent NeoplasmsPortugal
-
University of CoimbraFundação para a Ciência e a TecnologiaRecruitingBreast Cancer FemalePortugal
-
University College, LondonEuropean UnionCompletedEarly-Stage Breast CarcinomaUnited Kingdom, Netherlands, Portugal
-
SOLTI Breast Cancer Research GroupNovartis; UNICANCERRecruitingBreast Cancer Stage IISpain, France, Portugal
-
Grupo LusófonaCentro Hospitalar Universitario do Algarve; Universidade Lusófona de Humanidades... and other collaboratorsNot yet recruitingBreast Cancer | Chemotherapy EffectPortugal
-
University Institute of MaiaCentro Hospitalar de Vila Nova de Gaia/Espinho; Aveiro University; Associacao... and other collaboratorsRecruiting
-
Fundacao ChampalimaudUniversity of LisbonRecruiting
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Fundação para a Ciência e a... and other collaboratorsUnknownBreast Cancer | Breast NeoplasmsPortugal
-
Institut de Radioprotection et de Surete NucleaireInstitut Català d'Oncologia; Technical University of Munich; Hospital de Santa... and other collaboratorsCompletedBreast Cancer FemaleSpain, Germany, France, Netherlands, Portugal
-
University of MinhoFoundation for Science and Technology, PortugalCompletedBreast Cancer FemalePortugal
-
The Netherlands Cancer InstituteInstitut CurieTerminatedBreast Cancer | Neoplasms, Breast | Cancer of the BreastFrance, Netherlands, Portugal, Spain
-
Associacao de Investigacao de Cuidados de Suporte...Universidad Europea de Madrid; Centro Hospitalar de Vila Nova de Gaia/Espinho; University Institute of MaiaCompletedBreast CancerPortugal
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Australia, Greece, Spain, United States, United Kingdom, France, Israel, Malaysia, Japan, Belgium, Poland, China, Germany, Czechia, Singapore, Hungary, Brazil, Italy, South Africa, Portugal, Argentina, Hong... and more
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Associacao de Investigacao de Cuidados de Suporte...Centro Hospitalar de Vila Nova de Gaia/Espinho; Aveiro University; University...CompletedQuality of Life | Breast Cancer | Physical ExercisePortugal
-
MedSIRHoffmann-La RocheCompletedTriple Negative Breast CancerSpain, Portugal
-
Fundacao ChampalimaudEuropean Commission; Cankado GmbH; Bocconi University; INESC TEC - Institute for... and other collaboratorsRecruitingBreast CancerGermany, Israel, Italy, Portugal, Poland
-
SOLTI Breast Cancer Research GroupTerminated
-
Novartis PharmaceuticalsRecruitingBreast CancerFrance, Germany, Spain, Portugal
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
MedSIRPfizerCompletedBreast CancerSpain, Portugal
-
European Organisation for Research and Treatment...Central and Eastern European Oncology Group; Grupo Oncologico Cooperativo Chileno... and other collaboratorsTerminatedBreast CancerPoland, Belgium, Netherlands, Israel, United Kingdom, Chile, Portugal
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
European Organisation for Research and Treatment...Swiss Group for Clinical Cancer Research; Swedish Breast Cancer Group; Anglo...CompletedBreast CancerFrance, Switzerland, Poland, Sweden, Belgium, Netherlands, United Kingdom, Portugal, Slovenia
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High AmplificationItaly, United States, France, United Kingdom, Spain, Portugal, Canada
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy, Czechia, Mexico, Poland
-
Jules Bordet InstituteActive, not recruitingBreast CancerUnited States, Belgium, Israel, France, Italy, Spain, Brazil, Mexico, Poland, Portugal, Switzerland
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
AstraZenecaCompletedBreast CancerSweden, Czech Republic, France, Spain, United Kingdom, Hungary, Portugal
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Brazil, Mexico, Portugal
-
SanofiActive, not recruitingBreast CancerCzechia, Belgium, Spain, United States, France, Canada, Italy, Poland, Portugal, United Kingdom
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands